{"id":"W3096504089","doi":"10.1016/j.ophtha.2020.10.036","title":"Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis","year":2020,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; Allergan; Genentech; Alimera Sciences; Santen; Regeneron Pharmaceuticals; Gilead Sciences; Celldex Therapeutics; Pfizer; Aldeyra Therapeutics; NightstaRx; AbbVie; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Uveitis; Visual acuity; Placebo; Adverse effect; Intermediate uveitis; Macular edema; Ophthalmology; Corticosteroid; Surgery; Internal medicine; Anterior uveitis; Pathology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005659122,0.0002455051,0.0007067278,0.000117078,0.00003698622,0.00001202336,0.000103348,0.0001484344,0.00108642],"category_scores_gemma":[0.0001110384,0.0001894507,0.00008234663,0.0002374693,0.0002225414,0.00008475869,0.0001366448,0.0002055541,0.00001932332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005022845,"about_ca_system_score_gemma":0.0001174283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008539139,"about_ca_topic_score_gemma":0.00001912707,"domain_scores_codex":[0.9984519,0.00008628124,0.000443938,0.0004562307,0.000207186,0.0003544621],"domain_scores_gemma":[0.999114,0.00008703722,0.0001596872,0.0002546714,0.00008483529,0.0002997877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006270535,0.0006002395,0.9794891,0.0003065267,0.0001214478,0.005259582,0.0002119676,0.000001492559,0.0001023086,0.000003745524,0.00001465754,0.007618393],"study_design_scores_gemma":[0.01229862,0.008000977,0.9750445,0.000284568,0.0001484074,0.003875671,0.00002301744,0.000009336492,0.00007512914,0.000002637367,0.00003413502,0.0002029645],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981178,0.0002778445,0.000009188204,0.0003220799,0.000129715,0.0006831031,0.000111402,0.00003011664,0.0003187196],"genre_scores_gemma":[0.9991981,0.00005783934,0.00008603717,0.0002566467,0.00005757863,0.00001349611,0.0001775644,0.00004233594,0.0001104455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007415429,"threshold_uncertainty_score":0.9998267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01205284802840153,"score_gpt":0.2627004603660731,"score_spread":0.2506476123376716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}